循环miR-155与胃癌炎症因子相关性分析及在胃癌诊断中意义研究
Relationship between Circulating miR-155 and Inflammatory Factors in Gastric Carcinoma and Its Significance in the Diagnosis of Gastric Cancer
作者: 洪宏海 * , 陈金桃 , 林丽英 :广州医科大学附属第三医院检验科,广东 广州;
关键词: 胃癌; miR-155; 炎症因子; Gastric Cancer; miR-155; Inflammatory Factor
摘要:Abstract: Objective: To investigate the correlation between miR-155 and inflammatory factors in gastric cancer and its significance in the diagnosis of gastric cancer. Methods: The relative expression of miR-155 in serum of patients with gastric cancer detected by qRT-PCR; ELISA analysis the secre-tion of inflammatory cytokines including IL-1β, IL-6, IL-8 in gastric cancer cell line SGC-7901, si-lencing miR-155 by small molecule interference. Results: The level of miR-155 in serum of pa-tients with gastric cancer was significantly higher than that in healthy people, and ROC curve analysis showed that the serum miR-155 had a better diagnostic value in the diagnosis of gastric cancer. In addition, inflammatory cytokines IL-6, IL-8 levels were positively correlated with serum miR-155 level in serum of patients with gastric cancer gastric cancer; silencing of miR-155 inhibited inflammatory factor IL-1beta, IL-6, IL-8 secretion in gastric cancer cells. Conclusion: The level of miR-155 in serum is of significance in the diagnosis of gastric cancer, and it can regulate the secretion of inflammatory factors IL-1beta, IL-6 and IL-8 in gastric cancer.
文章引用: 洪宏海 , 陈金桃 , 林丽英 (2017) 循环miR-155与胃癌炎症因子相关性分析及在胃癌诊断中意义研究。 世界肿瘤研究, 7, 69-74. doi: 10.12677/WJCR.2017.73011
参考文献
[1]
Zhang, T., et al. (2013) Overexpression of Methionine Adenosyltransferase II Alpha (MAT2A) in Gastric Cancer and Induction of Cell Cycle Arrest and Apoptosis in SGC-7901 Cells by shRNA-Mediated Silencing of MAT2A Gene. Acta Histochemica, 115, 48-55.
https://doi.org/10.1016/j.acthis.2012.03.006
[2]
Nathan, C. and Ding, A. (2010) Nonresolving Inflammation. Cell, 140, 871-882.
https://doi.org/10.1016/j.cell.2010.02.029
[3]
Narita, Y. and Muro, K. (2017) Challenges in Molecular Targeted Therapy for Gastric Cancer: Considerations for Efficacy and Safety. Expert Opinion on Drug Safety, 16, 319-327.
https://doi.org/10.1080/14740338.2017.1273348
[4]
Guo, H., et al. (2010) Mammalian microRNAs Predominantly Act to Decrease Target mRNA Levels. Nature, 466, 835-840.
https://doi.org/10.1038/nature09267
[5]
Baulande, S., Criqui, A. and Duthieuw, M. (2014) Circulating miRNAs as a New Class of Biomedical Markers. Med Sci (Paris), 30, 289-296.
https://doi.org/10.1051/medsci/20143003017
[6]
Hessam, S., et al. (2017) Expression of miRNA-155, miRNA-223, miR-NA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa. Inflammation, 40, 464-472.
https://doi.org/10.1007/s10753-016-0492-2
[7]
Song, J. and Lee, J.E. (2015) miR-155 Is Involved in Alzheimer’s Disease by Regulating T Lymphocyte Function. Frontiers in Aging Neuroscience, 7, 61.
https://doi.org/10.3389/fnagi.2015.00061
[8]
Chung, H.W. and Lim, J.B. (2014) Role of the Tumor Microenvironment in the Pathogenesis of Gastric Carcinoma. World Journal of Gastroenterology, 20, 1667-1680.
https://doi.org/10.3748/wjg.v20.i7.1667
[9]
Harada, K., et al. (2017) Global Chemotherapy Development for Gastric Cancer. Gastric Cancer, 20, 92-101.
https://doi.org/10.1007/s10120-016-0655-8
[10]
Shaker, O., et al. (2015) Role of microRNAs-29b-2, -155, -197 and -205 as Diagnostic Biomarkers in Serum of Breast Cancer Females. Gene, 560, 77-82.
https://doi.org/10.1016/j.gene.2015.01.062
[11]
Strand, M.S., Lockhart, A.C. and Fields, R.C. (2017) Genetics of Gastric Cancer. Surgical Clinics of North America, 97, 345-370.
https://doi.org/10.1016/j.suc.2016.11.009
[12]
Fettelschoss, A., et al. (2011) Inflammasome Activation and IL-1beta Target IL-1alpha for Secretion as Opposed to Surface Expression. Proceedings of the National Academy of Sciences of the USA, 108, 18055-18060.
https://doi.org/10.1073/pnas.1109176108
[13] Lukaszewicz-Zajac, M., Mroczko, B. and Szmitkowski, M. (2010) The Role of Interleukin-6 and C-Reactive Protein in Gastric Cancer. Polski Merkuriusz Lekarski, 29, 382-386.